Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic

NCT04979897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 252

Last updated 2024-07-12

Study results available
· View outcomes & findings →

Summary

Intensive care unit (ICU) survivors and their families frequently present mental, cognitive and physical impairments lasting years. The ongoing pandemic could affect the duration, variety, and severity of these impairments. Our aim is to determine the impact of the COVID-19 pandemic on the physical, mental, and cognitive health of survivors, the experience of their families and their treating healthcare professionals in the long-term.

This is a prospective, multicentre, mixed-methods cohort study in seven Chilean ICUs. The perceptions of family members regarding the ICU stay and the later recovery will be explored 3 months after discharge. Health care professionals will be invited to discuss the challenges faced during the pandemic using semi-structured interviews.

Conditions

  • Covid19
  • Critical Care
  • Postintensive Care Syndrome

Interventions

OTHER

Intensive care unit stay during the COVID-19 pandemic

Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open \[close\] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study

Sponsors & Collaborators

  • Clinica Alemana de Santiago

    collaborator OTHER
  • Clinica Indisa

    collaborator OTHER
  • Clinica Bupa Santiago

    collaborator OTHER
  • Hospital del Salvador

    collaborator OTHER
  • Hospital Clínico Regional De Antofagasta Dr Leonardo Guzman

    collaborator OTHER
  • Hospital San Pablo de Coquimbo

    collaborator OTHER
  • Hospital Metropolitano

    collaborator OTHER
  • Universidad del Desarrollo

    lead OTHER

Principal Investigators

  • Ana Castro-Ávila, PhD · Universidad del Desarrollo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2021-11-02
Completion
2022-09-02

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04979897 on ClinicalTrials.gov